Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection

The CETP inhibitor, torcetrapib, was prematurely terminated from phase 3 clinical trials due to an increase in cardiovascular and noncardiovascular mortality. Because nearly half of the latter deaths involved patients with infection, we have tested torcetrapib and other CETPIs to see if they interfe...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Clark, Ronald W., Cunningham, David, Cong, Yang, Subashi, Timothy A., Tkalcevic, George T., Lloyd, David B., Boyd, James G., Chrunyk, Boris A., Karam, George A., Qiu, Xiayang, Wang, Ing-Kae, Francone, Omar L.
Формат: Artigo
Язык:Inglês
Опубликовано: The American Society for Biochemistry and Molecular Biology 2010
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2853464/
https://ncbi.nlm.nih.gov/pubmed/19965592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1194/jlr.M002295
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы